Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Relay Therapeutics, Inc.
Relay Therapeutics to Participate in Upcoming Investor Conferences
November 07, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights
November 06, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024
October 30, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Announces Pricing of Public Offering of Common Stock
September 10, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Announces Proposed Public Offering of Common Stock
September 09, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival
September 09, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024
September 06, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights
August 06, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024
July 30, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Discloses Three New Programs at New Program & Platform Event
June 06, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
June 05, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PFE
RLAY
Relay Therapeutics to Participate in Upcoming Investor Conferences
May 21, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
May 13, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
May 02, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024
April 25, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Participate in Upcoming Investor Conferences
April 11, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Participate in Three Upcoming Investor Conferences
February 26, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
February 22, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024
February 15, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 01, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Announces $30 Million Private Placement Financing
January 08, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Participate in Stifel 2023 Healthcare Conference
November 07, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Highlights
November 02, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Announce Third Quarter 2023 Financial Results and Corporate Highlights on November 2, 2023
October 26, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid Tumors
October 12, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Present Clinical Data on RLY-4008 in Advanced FGFR2-Altered Solid Tumors at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
September 18, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Highlights
August 08, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics to Announce Second Quarter 2023 Financial Results and Corporate Highlights on August 8, 2023
August 01, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Relay Therapeutics Announces Full Dose Escalation Data for RLY-4008
May 25, 2023
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.